University of Newcastle researcher Dr Bente Talseth-Palmer has received a three-year grant as part of the Cancer Institute NSW’s Early Career Development Fellowship program.
Her project aims to identify the genetic factors of inherited colon cancer, enabling at-risk relatives to be informed about their cancer risk and benefit from intensive screening programs.
NSW Health and Medical Research Minister Jillian Skinner awarded a total of $3.4 million this week to six researchers, including Dr Talseth-Palmer, who are forging careers to find new treatments and a cure for cancer.
“Few people can say their lives have not been touched by cancer so it is vital that we invest in fighting this terrible disease,” Mrs Skinner said.
“I am committed to ensuring our best and brightest researchers have the means to discover new treatments and potentially a cure for cancer to deliver better outcomes for patients here and across the globe.
“The work of these six researchers will ensure patients benefit from cutting-edge cancer research as their findings are translated into better treatments and care across the NSW health system.”
Professor David Currow, Chief Cancer Officer and CEO of the Cancer Institute NSW, said that investing in the future of cancer research will have a significant impact on the way we understand and treat cancers.
“I welcome this announcement as it gives certainty to our State’s finest and freshest researchers to undertake their important and potentially life-saving work,” he said.
HMRI is a partnership between the University of Newcastle, Hunter New England Health and the community.
Dr Bente Talseth-Palmer
